Covered recipient · General Payments record
IN HO HAN
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$3,899.34
- Reported across 202 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $376.75 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Abbott Laboratories | $138.88 | 7 |
| Amgen Inc. | $86.84 | 4 |
| Novo Nordisk AS | $41.51 | 2 |
| Acerta Pharma LLC | $35.24 | 2 |
| Lilly USA, LLC | $28.56 | 1 |
| Exact Sciences Corporation | $25.69 | 1 |
| PFIZER INC. | $20.03 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $21.53 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125230970 | CMS |
| Abbott Laboratories | $19.87 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125230974 | CMS |
| Abbott Laboratories | $19.98 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125230978 | CMS |
| Abbott Laboratories | $16.33 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125230982 | CMS |
| Abbott Laboratories | $15.44 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125230986 | CMS |
| Abbott Laboratories | $17.34 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125230994 | CMS |
| Abbott Laboratories | $28.39 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125230990 | CMS |
| Amgen Inc. | $15.72 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111593762 | CMS |
| Amgen Inc. | $21.09 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111593764 | CMS |
| Amgen Inc. | $23.70 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111593766 | CMS |
| Amgen Inc. | $26.33 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111593768 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.92 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104464410 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.32 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104486620 | CMS |
| Exact Sciences Corporation | $25.69 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114691272 | CMS |
| Lilly USA, LLC | $28.56 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135033698 | CMS |
| Novo Nordisk Inc | $18.98 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096711581 | CMS |
| Novo Nordisk Inc | $22.53 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096912962 | CMS |
| PFIZER INC. | $20.03 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131278061 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.